On air · 3 of 3 networks
Dana-Farber Cancer Institute
- dana-farber.org
- Healthcare & Life Sciences
- US
- 9,132 employees
Dana-Farber Cancer Institute’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 86. Watch Dana-Farber Cancer Institute with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 84 | Checked 28 Oct 2026 | See all 86 ads → | ||
| Meta | Running | 12 | Active ads on the Meta Ad Library, all countries | Checked 27 Oct 2026 | Collect them with the API → |
| Running | 100+ | Ads on the Google Ads Transparency Center | Checked 26 Oct 2026 | Collect them with the API → |
Dana-Farber Cancer Institute has 84 live LinkedIn ads. Its Facebook page had 12 active ads on 27 Oct 2026, and we recorded 100+ Google ads on 26 Oct 2026.
Latest ads
- LINKEDIN · JOBSince 21 Sept 2026
- LINKEDIN · JOBSince 12 May 2025
- LINKEDIN · IMAGERecorded 15 Sept 2026
Meet Evan Chen, MD, a medical oncologist who treats patients with acute leukemias and myeloid malignancies. Learn more about his clinic research, which focuses on the development of cellular therapies for leukemias and translational studies of leukemia epigenetics: https://bit.ly/4icGjli
- LINKEDIN · IMAGERecorded 15 Sept 2026
Menin inhibitors are a promising new class of drugs for acute leukemias. Richard Stone, MD, provides an update on our impact and ongoing clinical research efforts to advance menin inhibitor therapies for acute leukemias, aiming for effective and potentially all-oral treatments. https://bit.ly/3JUosTB
- LINKEDIN · IMAGERecorded 15 Sept 2026
Improvements in immunotherapy are leading to favorable results and reduced toxicities in treating patients with acute lymphoblastic leukemia. Get up to speed on the latest with Marlise R. Luskin, MD, MSCE: https://bit.ly/487e6rm
- LINKEDIN · IMAGERecorded 15 Sept 2026
Jacqueline Garcia, MD, is exploring ongoing clinical research to test novel triplet therapies for safety and efficacy with a precision medicine approach for patients with acute myeloid leukemia. Explore the latest updates: https://bit.ly/4r9CukM
6 of 86 adsSign up to see every Dana-Farber Cancer Institute ad, filter by format and date, and get alerts on new ones.
See all 86 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.